{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":20,"n_cols":5,"rows_kept":20,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[12,2,12,3],[13,2,13,3],[16,2,16,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910483139103321"]
[null,null,"Autore",null,"Wong Felix"]
[null,null,"Titolo",null,"Focused ultrasound surgery in gynecology : introduction and application / / Felix Wong, Lian Zhang, Zhibiao Wang"]
[null,null,"Pubbl/distr/stampa",null,"Singapore : , : Springer, , [2021]"]
[{"$nulls":4},"©2021"]
[null,null,"ISBN",null,"981-16-0939-X"]
[null,null,"Descrizione fisica",null,"1 online resource (114 pages) : illustrations"]
[null,null,"Disciplina",null,"300"]
[null,null,"Soggetti",null,"Gynecology"]
[{"$nulls":4},"Cirurgia obstètrica"]
[{"$nulls":4},"Ultrasons en medicina"]
[{"$nulls":4},"Llibres electrònics"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references."]
[null,null,"Nota di contenuto",null,"Intro -- Foreword -- Preface -- Declaration of Interest -- Contents -- About the Authors -- Abbreviations -- 1: An Introduction -- 1.1  The HAIFU Knife® -- 1.2  The \"HAIFU Knife®\" -- 1.2.1  Other Focused Ultrasound Equipment Systems in the Market -- 1.2.2  Ultrasound-Guided (USg) HIFU Systems -- 1.3  MRgHIFU Systems -- 1.4  Focused Ultrasound Hyperthermia Therapy and High Intensity Focused Ultrasound Ablation -- 1.5  Conclusion -- References -- 2: Sedation and Analgesia for HIFU Ablation -- 2.1  The Choice of Drugs for Sedation and Analgesia -- 2.2  First-Line Drugs -- 2.3  Second-Line Drugs -- 2.4  Other Auxiliary Drugs Should Be Available -- 2.4.1  Sedation and Analgesia Protocol for HIFU Ablation -- 2.5  Midazolam and Fentanyl Sedation Protocol -- 2.6  Other Sedation and Analgesic Regimes: Dexmedetomidine and Remifentanil Sedation Protocol -- 2.7  Monitoring During HIFU Surgery Under Sedation -- 2.8  Treatment of Complications -- 2.8.1  Respiratory Depression -- 2.8.2  Muscle Stiffness -- 2.9  Factors Affecting the Effects of Sedation and Analgesia -- References -- 3: Ultrasound and MRI Imaging of Uterine Fibroids and Adenomyosis -- 3.1  Imaging for Uterine Fibroids -- 3.1.1  Ultrasound Imaging -- 3.2  Locations of Fibroids -- 3.2.1  MRI Imaging -- 3.3  Uterine Adenomyosis -- 3.4  Transvaginal Ultrasound Appearances of Adenomyosis -- 3.5  MRI Appearances of Adenomyosis -- 3.6  Leiomyosarcoma and Endometrial Stromal Sarcoma-MRI "]
[{"$nulls":4},"Features -- References -- 4: Uterine Fibroids and HIFU Ablation -- 4.1  Symptoms of Uterine Fibroids -- 4.2  Indications for Treatment -- 4.3  Investigative Methods -- 4.4  Treatments -- 4.5  HIFU Treatment -- 4.6  The USgHIFU Ablation Procedure -- 4.7  The Indications for HIFU Treatment -- 4.8  The Contraindications for HIFU Ablation -- 4.9  Preparation Before HIFU Ablation -- 4.9.1  Simulation Test."]
[{"$nulls":4},"4.10  Other Preparations -- 4.11  HIFU Ablation -- 4.12  Factors Influencing HIFU Effectiveness -- 4.13  The Types and Locations of Fibroids that Affect HIFU Ablation -- 4.14  Assessment of the Effectiveness of the Ablation at the End of HIFU Ablation Procedure -- 4.15  Post-HIFU Ablation Care -- 4.16  Postoperative Follow-up -- 4.17  Results of HIFU Ablation on Follow-up -- 4.17.1  The Non-perfused Volume Ratio -- 4.17.2  The Volume Reduction After HIFU Ablation -- 4.18  Other Issues of Fibroid Ablation -- 4.19  Recurrence of Fibroids -- 4.20  Pregnancy After HIFU Ablation -- References -- 5: Adenomyosis and HIFU Ablation -- 5.1  The Symptoms of Adenomyosis -- 5.2  Treatment of Adenomyosis -- 5.2.1  Drug Treatment -- 5.2.1.1  Mirena (LNG-IUS) -- 5.2.1.2  Gonadotropin-Releasing Hormone Agonist (GnRH-a) -- 5.2.1.3  Oral Contraceptives -- 5.2.2  Surgical Treatment -- 5.2.3  Bilateral Uterine Artery Embolization (UAE) -- 5.2.4  High Intensity Focused Ultrasound (HIFU) Therapy -- 5.3  Factors Influencing HIFU Effectiveness for Adenomyosis Treatment are Listed as Follow -- 5.4  Advantages of HIFU Treatment for Adenomyosis -- 5.5  Pregnancy -- References -- 6: Complications of HIFU Ablation -- 6.1  Fever -- 6.2  Pain -- 6.3  Skin Burn Injury -- 6.4  Urinary Tract Injury -- 6.5  Bowel Injury -- 6.6  Vaginal Bleeding or Discharge -- 6.7  Other Rare Complications or Those Not Reported -- References -- 7: Fertility and Pregnancy After HIFU Ablation -- 7.1  The Reproductive Impact After HIFU Ablation for Uterine Fibroids -- 7.1.1  HIFU Impact on Ovarian Functions -- 7.1.2  HIFU Impact on Uterine Function -- 7.1.3  Risks of Miscarriage After HIFU Ablation -- 7.1.4  The Cesarean Section Rate After HIFU Ablation -- 7.2  The Reproductive Impact After HIFU Ablation for Adenomyosis -- 7.3  Conclusion -- References -- 8: Other Issues of HIFU Treatment."]
[{"$nulls":4},"8.1  MRI-Guided and Ultrasound-Guided HIFU Ablation -- 8.2  HIFU Ablation and HIFU Hyperthermia -- 8.3  Malignant Fibroids -- 8.4  Multiple Fibroids -- 8.5  The Cost of HIFU Treatment -- References -- 9: Other HIFU Ablation Applications in Gynecology and Related to Obstetrics -- 9.1  Abnormal Placenta Attachment-Placenta Accreta -- 9.2  Cesarean Scar Pregnancy (CSP) -- 9.3  Abdominal Wall Endometriosis -- References."]